Coeptis Therapeutics Holdings Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
/ 
Frequently asked questions
To buy Coeptis Therapeutics Holdings Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Coeptis Therapeutics Holdings Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Coeptis Therapeutics Holdings Inc. is COEP_NEW:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Coeptis Therapeutics Holdings Inc. has its primary listing on NASDAQ. You can trade Coeptis Therapeutics Holdings Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Coeptis Therapeutics Holdings Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Coeptis Therapeutics Holdings Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Coeptis Therapeutics Holdings Inc..